142 related articles for article (PubMed ID: 38737673)
1. Prognostic significance of alterations in fibrinogen level and fibrinogen-to-lymphocyte ratio after radiotherapy on survival outcomes in glioblastoma.
Huang R; Lu X; Sun X; Wu H
Transl Cancer Res; 2024 Apr; 13(4):1887-1903. PubMed ID: 38737673
[TBL] [Abstract][Full Text] [Related]
2. Elevated Pretreatment Fibrinogen-to-Lymphocyte Percentage Ratio Predict Tumor Staging and Poor Survival in Non-Small Cell Lung Cancer Patients with Chemotherapy or Surgery Combined with Chemotherapy.
Liu M; Yang J; Wan L; Zhao R
Cancer Manag Res; 2021; 13():4921-4933. PubMed ID: 34188545
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen/Lymphocyte Count Ratio Can Be Used as a New Indicator of Prognosis in Patients with Hepatocellular Carcinoma After Radical Resection.
Li Y; Li Z; Deng K; Liao M; Yuan S; Huang Z
Cancer Manag Res; 2020; 12():9057-9066. PubMed ID: 33061600
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen-to-lymphocyte Ratio Predicts the Outcomes of Hypopharyngeal Squamous Cell Carcinoma Treated With Definitive Radiotherapy.
Sato K; Hatakeyama H; Okada H; Kawano M; Yoshida K; Oki Y; Kuwahara T; Niwa K; Isono Y; Oridate N
In Vivo; 2023; 37(3):1281-1289. PubMed ID: 37103064
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of a combined fibrinogen and inflammation-based index in patients with metastatic breast cancer.
Liu Q; Fang S; Liang S; Lv J; Wang G; Tang R; Ji X; Zhao T; Li J; Xu L; Ma L; Wang R; Li H
Transl Cancer Res; 2020 Nov; 9(11):7065-7078. PubMed ID: 35117312
[TBL] [Abstract][Full Text] [Related]
6. Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma.
Li S; Zhang X; Lou C; Gu Y; Zhao J
Front Oncol; 2022; 12():1003845. PubMed ID: 36387142
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
Cai HX; Li XQ; Wang SF
World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
[TBL] [Abstract][Full Text] [Related]
8. A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio.
Fan N; Chen D; Zheng J; Wen Z; Lin P
Cancer Manag Res; 2019; 11():4719-4728. PubMed ID: 31213896
[No Abstract] [Full Text] [Related]
9. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment fibrinogen levels are associated with survival outcome in patients with cancer using immunotherapy as a second‑line treatment.
Xu R; Yang T; Yan B; You J; Li F; Zuo Q
Oncol Lett; 2023 Jun; 25(6):269. PubMed ID: 37216167
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.
Han Y; Ren Z; Liu Y; Liu Y
Ear Nose Throat J; 2024 May; 103(5):NP278-NP288. PubMed ID: 34672822
[TBL] [Abstract][Full Text] [Related]
12. Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients.
Wang Y; Wang Y; Chen R; Tang Z; Peng Y; Jin Y; Lan A; Ding N; Dai Y; Jiang L; Liu S
BMC Cancer; 2021 May; 21(1):542. PubMed ID: 33980202
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Lan M; Chen C; Huang Y; Mao M; Han F; Liao J; Deng M; Duan Z; Zheng L; Wu S; Lu T; Jian Y
Oncotarget; 2016 Jul; 7(29):46242-46252. PubMed ID: 27323828
[TBL] [Abstract][Full Text] [Related]
14. Preoperative low absolute lymphocyte count to fibrinogen ratio correlated with poor survival in nonmetastatic colorectal cancer.
Huang X; Huan Y; Liu L; Ye Q; Guo J; Yan B
World J Surg Oncol; 2022 Sep; 20(1):309. PubMed ID: 36153540
[TBL] [Abstract][Full Text] [Related]
15. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of preoperative plasma fibrinogen levels in primary gastrointestinal stromal tumours: a retrospective cohort study.
Song S; Cao X; Pan H; Hu M; Yan Q; Song J; Yang H; Zhao G; Xiao G
Int J Clin Oncol; 2020 Aug; 25(8):1506-1514. PubMed ID: 32577952
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen-to-Lymphocyte Ratio Was an Independent Predictor of Lymph Node Metastasis in Patients with Clinically Node-Negative Advanced-Stage Gastric Cancer.
Hu P; Wang W; He C
Int J Gen Med; 2023; 16():1345-1354. PubMed ID: 37089136
[TBL] [Abstract][Full Text] [Related]
18. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
[TBL] [Abstract][Full Text] [Related]
19. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Preoperative Fibrinogen to Albumin Ratio in Patients with Glioblastoma: A Singe Center Experience.
Li J; Zhou X; Xiang Y; Zhang S; Feng W; Yuan Y; Liu Y; Yin S
Cancer Manag Res; 2021; 13():3259-3269. PubMed ID: 33883939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
